Olshin, S <br/><br/>
Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.  [electronic resource] 

 -  Cancer chemotherapy reports  Apr 1972 
 - 259-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0069-0112 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkylating Agents--therapeutic use<br/>Carcinoma, Bronchogenic--drug therapy<br/>Carmustine--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Nitroso Compounds--therapeutic use<br/>Time Factors<br/>Urea--therapeutic use